- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Monoclonal Antibody Based Products market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Monoclonal Antibody Based Products market. Detailed analysis of key players, along with key growth strategies adopted by Monoclonal Antibody Based Products industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Immunomedics, Inc.
Human Genome Sciences, Inc.
Eli Lilly and Company
Johnson & Johnson
Biogen Idec AG
Centocor
Dendreon
MedImmune, Inc.
Schering-Plough Corporation
Medarex, Inc.
Elan Corporations Plc
Genentech, Inc.
CMC ICOS Biologices Corporation
PDL BioPharma
BD Biosciences Inc
Strategic Diagnostics Inc
Ortho Biotech Products, L.P.
Wyeth Pharmaceuticals
CMC ICOS Biologics, Inc.
Biotest, Inc.
UCB Group
By Type:
Murine
Chimeric
Humanized
Human
By End-User:
Therapeutics
Diagnostics
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal Antibody Based Products Market
-
1.3 Market Segment by Type
1.3.1 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Murine from 2014 to 2026
1.3.2 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Chimeric from 2014 to 2026
1.3.3 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Humanized from 2014 to 2026
1.3.4 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Human from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Therapeutics from 2014 to 2026
1.4.2 Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Diagnostics from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Monoclonal Antibody Based Products Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Monoclonal Antibody Based Products by Major Types
3.4.1 Market Size and Growth Rate of Murine
3.4.2 Market Size and Growth Rate of Chimeric
3.4.3 Market Size and Growth Rate of Humanized
3.4.4 Market Size and Growth Rate of Human
4 Segmentation of Monoclonal Antibody Based Products Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Monoclonal Antibody Based Products by Major End-Users
4.4.1 Market Size and Growth Rate of Monoclonal Antibody Based Products in Therapeutics
4.4.2 Market Size and Growth Rate of Monoclonal Antibody Based Products in Diagnostics
5 Market Analysis by Regions
-
5.1 Japan Monoclonal Antibody Based Products Production Analysis by Regions
-
5.2 Japan Monoclonal Antibody Based Products Consumption Analysis by Regions
6 Hokkaido Monoclonal Antibody Based Products Landscape Analysis
-
6.1 Hokkaido Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
6.2 Hokkaido Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
7 Tohoku Monoclonal Antibody Based Products Landscape Analysis
-
7.1 Tohoku Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
7.2 Tohoku Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
8 Kanto Monoclonal Antibody Based Products Landscape Analysis
-
8.1 Kanto Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
8.2 Kanto Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
9 Chubu Monoclonal Antibody Based Products Landscape Analysis
-
9.1 Chubu Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
9.2 Chubu Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
10 Kinki Monoclonal Antibody Based Products Landscape Analysis
-
10.1 Kinki Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
10.2 Kinki Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
11 Chugoku Monoclonal Antibody Based Products Landscape Analysis
-
11.1 Chugoku Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
11.2 Chugoku Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
12 Shikoku Monoclonal Antibody Based Products Landscape Analysis
-
12.1 Shikoku Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
12.2 Shikoku Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
13 Kyushu Monoclonal Antibody Based Products Landscape Analysis
-
13.1 Kyushu Monoclonal Antibody Based Products Landscape Analysis by Major Types
-
13.2 Kyushu Monoclonal Antibody Based Products Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Immunomedics, Inc.
14.1.1 Immunomedics, Inc. Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Human Genome Sciences, Inc.
14.2.1 Human Genome Sciences, Inc. Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Eli Lilly and Company
14.3.1 Eli Lilly and Company Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Johnson & Johnson
14.4.1 Johnson & Johnson Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Biogen Idec AG
14.5.1 Biogen Idec AG Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Centocor
14.6.1 Centocor Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Dendreon
14.7.1 Dendreon Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 MedImmune, Inc.
14.8.1 MedImmune, Inc. Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Schering-Plough Corporation
14.9.1 Schering-Plough Corporation Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Medarex, Inc.
14.10.1 Medarex, Inc. Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Elan Corporations Plc
14.11.1 Elan Corporations Plc Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Genentech, Inc.
14.12.1 Genentech, Inc. Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 CMC ICOS Biologices Corporation
14.13.1 CMC ICOS Biologices Corporation Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
14.14 PDL BioPharma
14.14.1 PDL BioPharma Company Profile and Recent Development
14.14.2 Market Performance
14.14.3 Product and Service Introduction
14.15 BD Biosciences Inc
14.15.1 BD Biosciences Inc Company Profile and Recent Development
14.15.2 Market Performance
14.15.3 Product and Service Introduction
14.16 Strategic Diagnostics Inc
14.16.1 Strategic Diagnostics Inc Company Profile and Recent Development
14.16.2 Market Performance
14.16.3 Product and Service Introduction
14.17 Ortho Biotech Products, L.P.
14.17.1 Ortho Biotech Products, L.P. Company Profile and Recent Development
14.17.2 Market Performance
14.17.3 Product and Service Introduction
14.18 Wyeth Pharmaceuticals
14.18.1 Wyeth Pharmaceuticals Company Profile and Recent Development
14.18.2 Market Performance
14.18.3 Product and Service Introduction
14.19 CMC ICOS Biologics, Inc.
14.19.1 CMC ICOS Biologics, Inc. Company Profile and Recent Development
14.19.2 Market Performance
14.19.3 Product and Service Introduction
14.20 Biotest, Inc.
14.20.1 Biotest, Inc. Company Profile and Recent Development
14.20.2 Market Performance
14.20.3 Product and Service Introduction
14.21 UCB Group
14.21.1 UCB Group Company Profile and Recent Development
14.21.2 Market Performance
14.21.3 Product and Service Introduction
The List of Tables and Figures (Totals 129 Figures and 151 Tables)
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Murine from 2014 to 2026
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Chimeric from 2014 to 2026
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Humanized from 2014 to 2026
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Human from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Therapeutics from 2014 to 2026
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Diagnostics from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Monoclonal Antibody Based Products Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Monoclonal Antibody Based Products Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Monoclonal Antibody Based Products
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Monoclonal Antibody Based Products by Different Types from 2014 to 2026
-
Table Consumption Share of Monoclonal Antibody Based Products by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Murine
Figure Market Size and Growth Rate of Chimeric
Figure Market Size and Growth Rate of Humanized
Figure Market Size and Growth Rate of Human
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Monoclonal Antibody Based Products by Different End-Users from 2014 to 2026
-
Table Consumption Share of Monoclonal Antibody Based Products by Different End-Users from 2014 to 2026
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Therapeutics from 2014 to 2026
Figure Japan Monoclonal Antibody Based Products Market Size and Growth Rate of Diagnostics from 2014 to 2026
-
Table Japan Monoclonal Antibody Based Products Production by Regions
-
Table Japan Monoclonal Antibody Based Products Production Share by Regions
-
Figure Japan Monoclonal Antibody Based Products Production Share by Regions in 2014
-
Figure Japan Monoclonal Antibody Based Products Production Share by Regions in 2018
-
Figure Japan Monoclonal Antibody Based Products Production Share by Regions in 2026
-
Table Japan Monoclonal Antibody Based Products Consumption by Regions
-
Table Japan Monoclonal Antibody Based Products Consumption Share by Regions
-
Figure Japan Monoclonal Antibody Based Products Consumption Share by Regions in 2014
-
Figure Japan Monoclonal Antibody Based Products Consumption Share by Regions in 2018
-
Figure Japan Monoclonal Antibody Based Products Consumption Share by Regions in 2026
-
Table Hokkaido Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Hokkaido Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Hokkaido Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Hokkaido Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
-
Table Tohoku Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Tohoku Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Tohoku Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Tohoku Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Tohoku Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Tohoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
-
Table Kanto Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Kanto Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Kanto Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Kanto Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Kanto Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Kanto Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Kanto Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Kanto Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Kanto Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
-
Table Chubu Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Chubu Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Chubu Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Chubu Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Chubu Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Chubu Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Chubu Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Chubu Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Chubu Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
-
Table Kinki Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Kinki Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Kinki Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Kinki Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Kinki Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Kinki Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Kinki Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Kinki Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Kinki Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
-
Table Chugoku Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Chugoku Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Chugoku Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Chugoku Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Chugoku Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Chugoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
-
Table Shikoku Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Shikoku Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Shikoku Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Shikoku Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Shikoku Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Shikoku Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
-
Table Kyushu Monoclonal Antibody Based Products Consumption by Types from 2014 to 2026
-
Table Kyushu Monoclonal Antibody Based Products Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Monoclonal Antibody Based Products Consumption Share by Types in 2014
-
Figure Kyushu Monoclonal Antibody Based Products Consumption Share by Types in 2018
-
Figure Kyushu Monoclonal Antibody Based Products Consumption Share by Types in 2026
-
Table Kyushu Monoclonal Antibody Based Products Consumption by End-Users from 2014 to 2026
-
Table Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users in 2014
-
Figure Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users in 2018
-
Figure Kyushu Monoclonal Antibody Based Products Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Immunomedics, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc.
Figure Sales and Growth Rate Analysis of Immunomedics, Inc.
Figure Revenue and Market Share Analysis of Immunomedics, Inc.
Table Product and Service Introduction of Immunomedics, Inc.
Table Company Profile and Development Status of Human Genome Sciences, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Human Genome Sciences, Inc.
Figure Sales and Growth Rate Analysis of Human Genome Sciences, Inc.
Figure Revenue and Market Share Analysis of Human Genome Sciences, Inc.
Table Product and Service Introduction of Human Genome Sciences, Inc.
Table Company Profile and Development Status of Eli Lilly and Company
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
Figure Revenue and Market Share Analysis of Eli Lilly and Company
Table Product and Service Introduction of Eli Lilly and Company
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of Biogen Idec AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec AG
Figure Sales and Growth Rate Analysis of Biogen Idec AG
Figure Revenue and Market Share Analysis of Biogen Idec AG
Table Product and Service Introduction of Biogen Idec AG
Table Company Profile and Development Status of Centocor
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Centocor
Figure Sales and Growth Rate Analysis of Centocor
Figure Revenue and Market Share Analysis of Centocor
Table Product and Service Introduction of Centocor
Table Company Profile and Development Status of Dendreon
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon
Figure Sales and Growth Rate Analysis of Dendreon
Figure Revenue and Market Share Analysis of Dendreon
Table Product and Service Introduction of Dendreon
Table Company Profile and Development Status of MedImmune, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune, Inc.
Figure Sales and Growth Rate Analysis of MedImmune, Inc.
Figure Revenue and Market Share Analysis of MedImmune, Inc.
Table Product and Service Introduction of MedImmune, Inc.
Table Company Profile and Development Status of Schering-Plough Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Schering-Plough Corporation
Figure Sales and Growth Rate Analysis of Schering-Plough Corporation
Figure Revenue and Market Share Analysis of Schering-Plough Corporation
Table Product and Service Introduction of Schering-Plough Corporation
Table Company Profile and Development Status of Medarex, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medarex, Inc.
Figure Sales and Growth Rate Analysis of Medarex, Inc.
Figure Revenue and Market Share Analysis of Medarex, Inc.
Table Product and Service Introduction of Medarex, Inc.
Table Company Profile and Development Status of Elan Corporations Plc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elan Corporations Plc
Figure Sales and Growth Rate Analysis of Elan Corporations Plc
Figure Revenue and Market Share Analysis of Elan Corporations Plc
Table Product and Service Introduction of Elan Corporations Plc
Table Company Profile and Development Status of Genentech, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc.
Figure Sales and Growth Rate Analysis of Genentech, Inc.
Figure Revenue and Market Share Analysis of Genentech, Inc.
Table Product and Service Introduction of Genentech, Inc.
Table Company Profile and Development Status of CMC ICOS Biologices Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CMC ICOS Biologices Corporation
Figure Sales and Growth Rate Analysis of CMC ICOS Biologices Corporation
Figure Revenue and Market Share Analysis of CMC ICOS Biologices Corporation
Table Product and Service Introduction of CMC ICOS Biologices Corporation
Table Company Profile and Development Status of PDL BioPharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PDL BioPharma
Figure Sales and Growth Rate Analysis of PDL BioPharma
Figure Revenue and Market Share Analysis of PDL BioPharma
Table Product and Service Introduction of PDL BioPharma
Table Company Profile and Development Status of BD Biosciences Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD Biosciences Inc
Figure Sales and Growth Rate Analysis of BD Biosciences Inc
Figure Revenue and Market Share Analysis of BD Biosciences Inc
Table Product and Service Introduction of BD Biosciences Inc
Table Company Profile and Development Status of Strategic Diagnostics Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Strategic Diagnostics Inc
Figure Sales and Growth Rate Analysis of Strategic Diagnostics Inc
Figure Revenue and Market Share Analysis of Strategic Diagnostics Inc
Table Product and Service Introduction of Strategic Diagnostics Inc
Table Company Profile and Development Status of Ortho Biotech Products, L.P.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ortho Biotech Products, L.P.
Figure Sales and Growth Rate Analysis of Ortho Biotech Products, L.P.
Figure Revenue and Market Share Analysis of Ortho Biotech Products, L.P.
Table Product and Service Introduction of Ortho Biotech Products, L.P.
Table Company Profile and Development Status of Wyeth Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wyeth Pharmaceuticals
Figure Sales and Growth Rate Analysis of Wyeth Pharmaceuticals
Figure Revenue and Market Share Analysis of Wyeth Pharmaceuticals
Table Product and Service Introduction of Wyeth Pharmaceuticals
Table Company Profile and Development Status of CMC ICOS Biologics, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CMC ICOS Biologics, Inc.
Figure Sales and Growth Rate Analysis of CMC ICOS Biologics, Inc.
Figure Revenue and Market Share Analysis of CMC ICOS Biologics, Inc.
Table Product and Service Introduction of CMC ICOS Biologics, Inc.
Table Company Profile and Development Status of Biotest, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest, Inc.
Figure Sales and Growth Rate Analysis of Biotest, Inc.
Figure Revenue and Market Share Analysis of Biotest, Inc.
Table Product and Service Introduction of Biotest, Inc.
Table Company Profile and Development Status of UCB Group
Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB Group
Figure Sales and Growth Rate Analysis of UCB Group
Figure Revenue and Market Share Analysis of UCB Group
Table Product and Service Introduction of UCB Group
-